SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-018498
Filing Date
2023-02-10
Accepted
2023-02-10 16:05:30
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2021 GP, L.L.C.GV 2021 GP, L.P.GV 2021, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm235939d1_sc13g.htm SC 13G 195164
2 EXHIBIT 99.1 tm235939d1_ex99-1.htm EX-99.1 21594
  Complete submission text file 0001104659-23-018498.txt   218455
Mailing Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2019, L.P. (Filed by) CIK: 0001845041 (see all company filings)

IRS No.: 384092634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Subject) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93800 | Film No.: 23611781
SIC: 2836 Biological Products, (No Diagnostic Substances)